Research conducted by CQU’s (Central Queensland University) International Program for Psycho-Social Health Research (IPP-SHR) has found that administrative issues are blocking the Patient Transport Assistance Scheme (PTAS) from providing equitable access to cancer treatments for rural, remote and regional Queenslanders.
A team of international scientists has decoded the genome of the parasite behind trichomoniasis, a sexually transmitted infection (STI) that each year affects about 170 million people worldwide.
Researchers at Mayo Clinic in Jacksonville, Fla. and the National Taiwan University Hospital in Taipei, Taiwan have discovered what to date appears to be the most common genetic risk factor for Parkinson?’s disease worldwide.
Switching patients to more cost-effective drugs for cholesterol and blood pressure problems could reduce health budgets by billions without compromising clinical care, according to a study in the January issue of IJCP, the International Journal of Clinical Practice. No adverse events were reported after patients were switched — the new cholesterol drugs delivered the same results as the previous drug and the new blood pressure drugs delivered improved performance.
CNRS (France) researchers have developed a novel synthetic process for bio degradeable materials that could be used instead of traditional medication in the form of tablets, capsules or syrups. This study was published on 27 December 2006 in the Journal of the American Chemical society.
Brain injury causes glutamate, a substance necessary for proper brain function, to flood areas surrounding the trauma and kill other cells. Weizmann Institute scientists have developed a new way to rid the brain of excess glutamate. This method — which uses an enzyme found in blood — could lead to new therapies not only for brain injury, but also for stroke and other conditions, and holds promise for prevention of damage from meningitis or nerve gas.
Virginia Commonwealth University Massey Cancer Center researchers have identified an approach to enhance the activity of a new anti-cancer agent that has already shown impressive efficacy in the treatment of chronic myelogenous leukemia.
“Companies, workers and investors alike are being challenged by the uncertainties surrounding nanotechnology workplace safety. These uncertainties include lack of sound, scientific information on occupational risks, poorly determined perceptual risks, and hesitancy over nanotechnology oversight,” according to co-authors Andrew Maynard and David Y.H. Pui in an article in the latest issue of the Journal of Nanoparticle Research. This is a special journal issue devoted to nanoparticles and occupational health.
A new surgical technique pioneered at the University of Alberta has given back the ability to swallow to patients with tongue cancer.
Researchers have found a marker on head and neck tumor cells that indicates which cells are capable of fueling the cancer’s growth. The finding is the first evidence of cancer stem cells in head and neck tumors.